Loughborough University
Browse
- No file added yet -

Flow rate-rise time profiles from model dry powder inhaler (DPI) testing of abbreviated impactor systems compared with their full resolution counterparts: Initial experimental data

Download (317.17 kB)
conference contribution
posted on 2022-12-22, 12:50 authored by Jolyon Mitchell, Daryl Roberts, Hendrik VersteegHendrik Versteeg, Andrew Cooper, Mark Copley, Roland Greguletz

We report the outcome of a European Pharmaceutical Aerosol Group study evaluating flow rate-rise times for reduced Next Generation Impactor (rNGI), Fast-Screening Impactor (FSI) and Fast-Screening Andersen impactor (FSA) with surrogate low-, medium- and high-resistance DPIs. Time for the flow rate to reach 90% of target (t90) and flow acceleration rate (slopet20/t80) defined the profiles. Volumes of the abbreviated impactors were estimated (±10mL) and compared to published values for their counterpart parent impactors (rNGI and FSI to NGI; FSA to Andersen Cascade Impactor (ACI)). t90 (n=3 replicates; mean±S.D.) for rNGI (system volume 1990 mL, participant D) for target flow rates of 30 and 60 L/min were 387±5 and 218±8 ms respectively, close to corresponding values of 400±7 and 219±6 ms for the NGI (2000 mL). The slopet20/t80) values were 0.09±0.00 and 0.31±0.00 L/min/ms at 30 and 60 L/min for the rNGI, also similar to the NGI value. Values of t90 (170±5; 76±2 ms) and slopet20/t80 (0.22±0.01; 0.96±0.01 L/min/ms) with the smaller FSI (1150 mL), were significantly different at 30 and 60 L/min respectively than those of the NGI. Participant G found similar divergences including tests at 90 L/min (t90 60±3 ms (FSI); 185±6 ms (NGI). When testing two FSAs (volume of 630 mL) at 60 L/min, Participant J found almost identical t90 values (70±3; 71±2 ms), shorter than 60-L/min values (151±3; 162±6 ms) for their two ACIs (larger volume, 1180 ml). Apparatus internal volume is an important determinant of flow rate-rise time.

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Drug Delivery to the Lungs (DDL) 2022

Volume

33

Source

Drug Delivery to the Lungs (DDL) 2022 conference

Publisher

Drug Delivery to the Lungs

Version

  • AM (Accepted Manuscript)

Rights holder

© DDL

Publisher statement

This is paper was presented at the Drug Delivery to the Lungs (DDL) 2022 conference in Edinburgh, UK. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Acceptance date

2022-10-11

Publication date

2022-12-07

Language

  • en

Location

Edinburgh, UK

Event dates

7th December 2022 - 9th December 2022

Depositor

Hendrik Versteeg. Deposit date: 20 December 2022

Usage metrics

    Loughborough Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC